CLDI

Calidi Biotherapeutics, Inc.

There isn't enough reported data to score CLDI yet.

CLDI Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Unavailable

CLDI's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.

CLDI PE Valuation

CLDI has no meaningful PE right now: it lost money over the past year.

CLDI Forward outlook

There aren't enough analyst estimates for CLDI to show an outlook.

CLDI Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $0.66 on Nov 12.

There is not enough scenario data to assess CLDI's risk to reward.

CLDI Earnings Per Share

Q4 2024: $-915.84Q1 2025: $-566.40Q2 2025: $-329.44Q3 2025: $-240.00
Q4 2024: $-915.84Q1 2025: $-566.40Q2 2025: $-329.44Q3 2025: $-240.00

CLDI lost $240.00 per share over the past year, a smaller loss than the year before.

CLDI Quarterly Revenue

Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --
Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --

CLDI Free Cash Flow

Q3 2023: −$22MQ4 2023: −$5MQ1 2024: −$4MQ2 2024: −$5MQ3 2024: −$5MQ4 2024: −$5MQ1 2025: −$7MQ2 2025: −$5MQ3 2025: −$4MQ4 2025: −$5MQ1 2026: −$4MQ2 2026: −$4M
Q3 2023: −$22MQ4 2023: −$5MQ1 2024: −$4MQ2 2024: −$5MQ3 2024: −$5MQ4 2024: −$5MQ1 2025: −$7MQ2 2025: −$5MQ3 2025: −$4MQ4 2025: −$5MQ1 2026: −$4MQ2 2026: −$4M
QuarterFree cash flowYoY
Q2 2026-$4.4M+$527K
Q1 2026-$4.1M+$3M
Q4 2025-$5M+$379K
Q3 2025-$4.2M+$708K
Q2 2025-$4.9M+$614K
Q1 2025-$7.1M-$3.3M
Q4 2024-$5.4M-$237K
Q3 2024-$4.9M+$17.4M

CLDI has burned cash in almost every quarter: −$18M over the past year, against −$22M the year before.

CLDI Total Shares

Q3 2023: 7,453Q1 2024: 18,517Q2 2024: 27,750Q3 2024: 40,750Q4 2024: 41,693Q1 2026: 644,250Q2 2026: 1M
Q3 2023: 7,453Q1 2024: 18,517Q2 2024: 27,750Q3 2024: 40,750Q4 2024: 41,693Q1 2026: 644,250Q2 2026: 1M
PeriodChange %Net change
Quarterly+120%+772K shares
1 year+5003%+1.4M shares
3 years+9394%+1.4M shares

CLDI has 1M diluted shares, up 5003% from a year ago.

CLDI Net Leverage

CLDI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

CLDI Weekly Momentum

MetricValueStatus
RSI24.5Oversold
Stochastic4.9Oversold

CLDI's weekly RSI is 25 (oversold) and its Stochastic is 5 (oversold).

CLDI PE vs Healthcare Sector

CLDI has no meaningful PE right now: it lost money over the past year.

CLDI Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$0.8522% below
20 week MA$1.3150% below
50 week MA$6.2889% below
100 week MA$52.899% below
200 week MA$3,884.4100% below

CLDI is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.

CLDI Yearly ROI

YearStart priceEnd priceROI
2021$18,873.6$18,854.4-0.1%
2022$18,854.4$19,200.0+1.8%
2023$19,200.0$2,899.2-85%
2024$2,899.2$257.3-91%
2025$257.3$19.8-92%
2026 YTD$19.8$0.66-97%

CLDI has finished three years in a row lower, and it's down 97% so far in 2026.

Give your agent the market.

Get API key